Intracellular antioxidant activity of biocompatible citrate-capped palladium nanozymes by Moglianetti, M. et al.
nanomaterials
Article
Intracellular Antioxidant Activity of Biocompatible
Citrate-Capped Palladium Nanozymes
Mauro Moglianetti 1,*,† , Deborah Pedone 1,† , Gayatri Udayan 1,2, Saverio Francesco Retta 3 ,
Doriana Debellis 4, Roberto Marotta 4, Antonio Turco 5 , Simona Rella 5, Cosimino Malitesta 5 ,
Giulia Bonacucina 6, Elisa De Luca 1,* and Pier Paolo Pompa 1,7,*
1 Nanobiointeractions & Nanodiagnostics, Center for Biomolecular Nanotechnologies, Istituto Italiano di
Tecnologia, via Barsanti, 73010 Arnesano, Lecce, Italy; deborah.pedone@iit.it (D.P.);
gayatriudayan@gmail.com (G.U.)
2 Department of Engineering for Innovation, University of Salento, Via per Monteroni, 73100 Lecce, Italy
3 Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (Torino), Italy;
francesco.retta@unito.it
4 Electron Microscopy Laboratory, Nanochemistry Department, Istituto Italiano di Tecnologia, via Morego 30,
16163 Genova, Italy; doriana.debellis@iit.it (D.D.); roberto.marotta@iit.it (R.M.)
5 Dipartimento di Scienze e Tecnologie Biologiche e Ambientali (Di.S.Te.B.A.), Università del Salento,
via Monteroni, 73100 Lecce, Italy; antonio.turco@unisalento.it (A.T.); simona.rella@unisalento.it (S.R.);
cosimino.malitesta@unisalento.it (C.M.)
6 School of Pharmacy, Via Gentile III da Varano, University of Camerino, 62032 Camerino, Italy;
giulia.bonacucina@unicam.it
7 Nanobiointeractions & Nanodiagnostics, Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova, Italy
* Correspondce: mauro.moglianetti@iit.it (M.M.); elisa.deluca@iit.it (E.D.L.); pierpaolo.pompa@iit.it (P.P.P.)
† Equally contributing authors.
Received: 28 November 2019; Accepted: 28 December 2019; Published: 3 January 2020


Abstract: A method for the aqueous synthesis of stable and biocompatible citrate-coated palladium
nanoparticles (PdNPs) in the size range comparable to natural enzymes (4–8 nm) has been developed.
The toxicological profile of PdNPs was assessed by different assays on several cell lines demonstrating
their safety in vitro also at high particle concentrations. To elucidate their cellular fate upon uptake, the
localization of PdNPs was analyzed by Transmission Electron Microscopy (TEM). Moreover, crucial
information about their intracellular stability and oxidation state was obtained by Sputtering-Enabled
Intracellular X-ray Photoelectron Spectroscopy (SEI-XPS). TEM/XPS results showed significant
stability of PdNPs in the cellular environment, an important feature for their biocompatibility and
potential for biomedical applications. On the catalytic side, these PdNPs exhibited strong and broad
antioxidant activities, being able to mimic the three main antioxidant cellular enzymes, i.e., peroxidase,
catalase, and superoxide dismutase. Remarkably, using an experimental model of a human oxidative
stress-related disease, we demonstrated the effectiveness of PdNPs as antioxidant nanozymes within
the cellular environment, showing that they are able to completely re-establish the physiological
Reactive Oxygen Species (ROS) levels in highly compromised intracellular redox conditions.
Keywords: palladium nanoparticles; aqueous synthesis; nanozymes; oxidative stress; antioxidants;
scavengers; toxicology; SEI-XPS
1. Introduction
Palladium nanoparticles (PdNPs) represent a promising player in nanomedicine and
nanodiagnostics, due to their efficient and broad catalytic activities [1–7] that are opening the way to
a variety of applications [8]. In particular, their use as catalyst/nanozyme for chemical reactions of
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therapeutic relevance within cellular environment would be of great interest. Up to now, however, only
few promising reports have proposed the use of PdNPs, showing that they can catalyze the conversion
of inactive prodrugs into toxic drugs directly within cells, thus enabling local chemotherapy [1,9–13].
The catalytic properties of PdNPs confer them the ability to act as artificial antioxidant nano-enzymes
(nanozymes) [2–4,14,15] for potential applications in the study of the pathogenesis and treatment of
oxidative stress-related diseases. Preliminary data suggest that PdNPs possess radical scavenging
activity similar to that of natural enzymes, namely catalase (CAT) [14,16], peroxidase (HRP) [3,16,17],
and superoxide dismutase (SOD) [14,15], but these studies are limited to a few cases, in a cell-free
environment, and do not provide a clear picture of their structure-function relationship [18]. Moreover,
despite such interesting features, the biomedical use of PdNPs is still limited, partially due to conflicting
data about their toxicity [19–27]. In this regard, the presence of synthesis by-products, endotoxins,
contaminations, and surface functionalities has a strong influence and could be the reason of the
observed toxicity in many reports [28]. Therefore, the determination of the toxicological profile of
the nanomaterial is still missing, even though it is crucial for the applications of Pd in the field
of nanomedicine [29]. A clearer picture of the toxicological profile of PdNPs would promote the
exploitation of their catalytic activities in the medical field for developing novel nanocatalysts or drug
delivery nanosystems with therapeutic properties.
We developed a new protocol of synthesis preferentially based on biocompatible, green, or
biogenic reagents and aqueous environment to obtain monodisperse and biocompatible PdNPs, only
covered by citrate molecules. Two different sizes, 4 and 8 nm, were synthesized to match the size
range of natural enzymes. With this highly purified material, we performed a systematic toxicity
assessment, demonstrating their safety in vitro up to high particle concentrations. Inductively Coupled
Plasma Atomic Emission spectroscopy (ICP-AES) and Transmission Electron Microscopy (TEM) along
with a recently developed technique, namely Sputtering-Enabled Intracellular X-Ray Photoelectron
Spectroscopy (SEI-XPS) [30], were used to investigate the PdNP cellular uptake and fate. After a
detailed characterization on the antioxidant properties of PdNPs, we proved their potential to function
as antioxidant nanozymes in a cell line model of a human oxidative stress-related disorder.
2. Results
2.1. Aqueous Synthesis of PdNPs and Physico-Chemical Characterization
The application of nanomaterials in nanomedicine and nanodiagnostics requires a strict
control of their physico-chemical properties, achievable by a careful design of the synthetic
procedure [5,7,28,31–40]. To this purpose, we developed a new protocol for the synthesis of PdNPs
that provides low polydispersity along with size tunability, combined with reagents known to be
biocompatible, green, or easy to remove after synthesis. All syntheses were performed using BioXtra
and BioUltra pure reagents in aqueous environment, with extensive post-synthesis purification. This is
important for the application of these NPs, as it should guarantee the absence of toxicity factors other
than the material per se, i.e., contaminants, endotoxins, and reaction by-products [34,39,41,42].
The main reagent in the synthesis was sodium citrate, which plays a role in both reducing and
stabilizing the nanoparticles. As citrate molecules have carboxylic and hydroxyl groups, they weakly
bind the surface of PdNPs stabilizing the particles in solution against aggregation. Moreover, they only
partially cover NP surface and can easily be removed. In this way, a “naked” surface, a pivotal aspect
for catalysis/nanozyme applications, can be obtained without major cleaning processes, unlike synthetic
protocols based on polymers or strong surfactants [41]. Furthermore, the proposed procedure tries to
strictly follow the “green” synthesis requirements, as it uses water as solvent and only cytocompatible
compounds, an important feature considering the strong need to develop low environmental-impact
synthetic protocols of nanomaterials [41].
Monodisperse citrate-capped PdNPs with a diameter of 4 nm (Pd4) were obtained by combining
sodium citrate and sodium borohydride, in order to promote a quick and uniform growth of the
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nanomaterial with spherical geometry (Figure 1A,B). 8 nm PdNPs (Pd8) (Figure 1C,D) were obtained
by seed-growth method using only sodium citrate, formic acid, and L-ascorbic acid with a reaction
time of circa 10 min. The size tunability was achieved also by the control of the reaction rate [43]: By
dissolving the PdCl2 precursor in different acidic media (0.1 M HNO3 or CH3COOH), different Pd
complexes are formed with different stability and, hence, reduction kinetics [34]. The synthesis was
also scaled-up by employing a microwave reactor, with multi-vessel setup, achieving a production
yield of circa 50/60 mg PdNPs per hour.
PdNPs were characterized by TEM imaging, which revealed the formation of spherical PdNPs
with low polydispersity and size distributions centered around 4 and 8 nm (Figure 1). The inset
of Figure 1 shows that the nanoparticles were well separated also after the deposition on the TEM
grids, despite being only covered by citrate molecules. To the best of our knowledge, this is the first
synthetic protocol that achieves the production of monodisperse PdNPs with size tunability, using only
sodium citrate as a capping agent in aqueous environment [5,44–46]. This is particularly important, as
the majority of PdNP syntheses described in the literature requires the use of organic solvents and
difficult-to-remove capping agents (polymers, surfactants, and/or thiolated molecules), two features
that can strongly affect the catalytic properties and the toxicological profile of the nanomaterial.
Before biological assessments, the Limulus test [47] was used to confirm the absence of endotoxins
in the solution.
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Figure 1. Representative Transmission Electron Microscopy (TEM) micrographs and nanoparticle 
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Figure 1. Representative Transmission Electron Microscopy (TEM) micrographs and nanoparticle (NP)
size distribution analyses of Pd4 (A,B) and Pd8 (C,D). Scale bars in the insets: 10 nm.
2.2. Toxicity Assessment of PdNPs
A careful study of the toxicological profile and intracellular fate of NPs is crucial to
uncover their biomedical potential [28,31,33]. Although there are several studies reported in the
literature [1,9,10,13,14,19–27,48–54], there is a lack of conclusive data about the biocompatibility
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of PdNPs. The results are rather conflicting, likely due to the high variety of PdNP synthetic
protocols, dimensions, shapes, surface capping agents, purity, cellular lines used for toxicity tests,
and the variability of experimental conditions. In vitro and in vivo studies reported cytocompatibility
for pristine PdNPs and PdNPs coated with biocompatible compounds [14,51,54,55], while others
reported cytotoxic effects, as a consequence of Pd ion release [25] or Reactive Oxygen Species (ROS)
overproduction [27]. Here, we performed a systematic in vitro assessment on monodisperse and pure
citrate-capped Pd4 and Pd8, by monitoring their effects on cellular metabolism, membrane integrity,
and ROS levels (through Water Soluble Tetrazolium salt (WST-8), Lactate Dehydrogenase (LDH),
and 2′,7′-Dichlorofluorescein diacetate (DCFH-DA) assays), and evaluating their cellular uptake by
Inductively Coupled Plasma Atomic Emission spectroscopy (ICP-AES) and Transmission Electron
Microscopy (TEM). Moreover, to characterize NP stability/degradation and oxidation state within
the cellular environment, we exploited a recently developed technique, namely Sputtering-Enabled
Intracellular X-Ray Photoelectron Spectroscopy (SEI-XPS) [30].
We evaluated the impact of increasing concentrations of Pd4 and Pd8 by performing WST-8
cytotoxicity assays after 24, 48, and 72 h of treatment (Figure 2). We observed that, independently of
their size, PdNPs do not reduce viability of HeLa (Figure 2A,B), MCF-7 (Figure 2C,D), and Caco-2
(Figure 2E,F) cells, even at high NP concentration (50 µg/mL). These data are in line with other
literature reports showing that PdNPs coated by biocompatible materials do not cause cellular damage
in vitro [14,56].
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To strengthen the information regarding the toxicological profile of PdNPs, we assessed the
integrity of cellular membranes by lactate dehydrogenase (LDH) assay, since it has been previously
reported that cellular treatment with metal nanoparticles may induce membrane damage [57–59], even
without inducing detectable alteration of mitochondrial activity. We found that the membrane integrity
of HeLa, MCF-7, and Caco-2 cells was not affected by exposure to Pd4 and Pd8, also by using higher
particle concentration (up to 100 µg/mL) (Figure 3).
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In addition, to evaluate possible alteration of ROS homeostasis due to PdNP internalization,
we quantified the intracellular levels of ROS by 2′,7′-Dichlorofluorescein diacetate (DCFH-DA)
assay [60,61], as in some studies oxidative stress has been described as one of the processes of PdNP
cellular toxicity [24,27]. HeLa and Caco-2 cells were treated for 24 h with high doses of PdNPs (up to
100 µg/mL) (Figure 4). We observed that, regardless of their size and concentration, PdNPs do not alter
ROS intracellular basal levels, thus, providing a further hint of their biocompatibility. Taken together,
these results show that our citrate-capped PdNPs with size below 10 nm do not affect cellular viability,
membrane integrity of cells, and ROS homeostasis, also at high concentrations.
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The study of NP internalization and their intracellular fate is of fundamental relevance to
understand the mechanisms of their toxicity. To analyze the uptake of PdNPs, we measured by ICP-AES
the content of Pd in HeLa and Caco-2 cells exposed to 50 µg/mL of Pd4 for 24 h (Supplementary
Table S1). The results show an abundant uptake of PdNPs, in line with previous reports for other metal
NPs [39,62]. In particular, we found a cell type-dependent internalization of nanoparticles, because
Caco-2 cells endocytosed circa one tenth of the particles internalized by HeLa cells (Supplementary
Table S1), likely due to their different cell body dimensions. This is in qualitative agreement with
previous studies with other metal NPs [39,63]. We then imaged by TEM the subcellular localization of
PdNPs in HeLa cells, upon exposure to Pd4 and Pd8 for 24 h. As shown in Figure 5 and in Supporting
Figure S1, NPs were internalized in cells by the endo-lysosomal pathway and confined into late
endosomal and/or lysosomal compartments. TEM micrographs mostly show small particle aggregates
dispersed into endo/lysosomes, with some single NPs also present (especially for Pd4). Interestingly,
analyzing the size of the internalized particles, we observed that PdNPs typically maintain their
pristine size after 24 h. This suggests that the particles do not undergo significant dissolution when
exposed to the acidic and degradative environment of lysosomes, unlike for instance silver NPs [40,57].
In light of these results, the biocompatibility of PdNPs could be ascribed to the stability of the material
(i.e., resistance to the acidic corrosion) in the cellular environment and absence of significant Pd ion
release. Moreover, considering the interplay of particle physico-chemical properties with surface
coatings and possible contaminants in determining NP toxicological profile, our results confirm the
purity of the nanomaterial synthesized. This is a fundamental aspect for the introduction of new
nanozymes in nanobiomedicine.
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2.3. PdNP Cellular Fate by SEI-XPS
ong the recently developed tools to assess the fate of nano aterials in biological systems,
SEI-XPS represents a valuable technique, as it per its co plete che ical assess ent of inorganic
nanoparticle fate within cells, i.e., their in-situ stability/degradation and oxidation state, with nanoscale
vertical resolution [30]. Figure 6A reports a representative high-resolution spectrum of the Pd 3D region
of PdNPs before incubation in cell culture medium. The signal is split in two peaks with well-defined
ratio, due to the spin–orbit coupling effects. These spectra can be fitted in two pairs of doublets.
The signal at 335.0 eV can be ascribed to zero valent palladium, while the s all peak at 337.1 eV is due
to Pd oxidized species in the pristine material (Pd-oxpr), in agreement with previous studies [64]. Such
low percentage of oxidized species of Pd is likely due to some ageing of the material once exposed to
air for several days before the measurement. XPS characterization was directly performed on HeLa
cells, previously incubated with PdNPs for 48 h. Supporting Figure S2a,b shows a representative
survey spectrum, in which the signals of the chemical elements constituting the cell membrane, such as
C, O, N, P, Na, and Cl, are clearly visible. Si signals are weak, demonstrating that the glass support was
almost completely coated by cells on the measurement area (circa 700 × 300 µm2). Moreover, Pd 3d
signals were not present (Supporting Figure S2c), suggesting that there are not PdNPs on the exterior
surface of the cellular layer (~10 nm), corresponding to the cellular membrane or the cytosol close to it.
This result is due to the efficacy of the extensive washing protocol applied before the measurement
that permits the complete removing of NPs weakly bound to the cell surface. To further investigate
intracellular NP distribution, argon sputtering was used to etch the surface layer and expose the
intracellular environment. In Supporting Figure S2d,e a survey spectrum collected following argon
sputtering (300 s) is reported. The intensities of photoelectron lines related to Si, Cl, P, and Na became
relevant, as the intracellular environment is exposed due to the etching performed by argon sputtering.
Furthermore, two peaks at binding energies (BE) of 335.2 and 340.6 became evident (Supporting Figure
S2f) and were ascribed to Pd 3D photoemission. High-resolution XPS peaks of the Pd 3d obtained
from cells exposed to PdNPs were fitted, as shown in Figure 6B. Pd 3D peaks exhibited a broadening
with respect to pristine NPs (Figure 6A) and at least two more spin−orbit pairs of components became
evident. These spectra related to Pd within cells could be fitted into four pairs of doublets with binding
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energies for Pd 3d5/2 of 335.0 ± 0.2, 337.1 ± 0.2, 336.3 ± 0.2, and 338.2 ± 0.2 [65]. The relative intensities
of the four components were quantified to be 60.1 ± 0.2%, 6.3 ± 0.2%, 20.2 ± 1.3, and 13.4 ± 1.3%,
respectively. The two new signals at 336.3 and 338.2 eV were ascribed to Pd oxidized species (Pd-ox1
and Pd-ox2, likely Pd(II) and Pd(IV)) due to the NP surface oxidation, which was elicited by the
intracellular environment. Indeed, we verified that argon sputtering does not modify the nanomaterial,
as longer sputtering times did not alter the proportion between the four components. This confirms
that the cell etching treatment does not induce detectable modifications of the oxidation state of PdNPs
(Supporting Figure S3). The overall percentage of the oxidized Pdox1 and Pdox2 species, due to the
endo-lysosomal environment, was approximately ~33% and was most likely due to the oxidation of
the superficial Pd atoms after the binding of thiolated molecules (e.g., glutathione), highly present
within the cellular environment. However, PdNPs did not undergo dissolution, as also proven by the
TEM analysis showing that NPs maintain their pristine size. The percentage of oxidized material was
comparable to the one previously observed for PtNPs, while AgNPs were found to be completely
oxidized and dissolved after 48 h within the cellular environment [30].
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Figure 6. (A) High-resolution X-Ray Photoelectron Spectroscopy (XPS) spectra of the Pd 3D region with
relative fits of PdNPs after deposition on a glass substrate. Data are shown in black and their fits are as
follows: Pd(0) in red, Pdoxpr in green, and fitted peaks sums in gray dashed lines. (B) High-resolution
XPS spectra of the Pd 3D region for HeLa cells after treatment with PdNPs for 48 h after 300 s of argon
sputtering time. Data are shown in black and their fits are as follows: Pd(0) in red, Pdox1 in blue, Pdox2
in pink, Pdoxpr in green, and fitted peaks sums in gray dashed lines.
These results underline that PdNPs can withstand the harsh endo-lysosomal environment without
showing significant dissolution. This is a crucial information for the evaluation of the cytotoxic effect
of NPs, as the release of toxic ions within the cells represents one of the main mechanisms behind the
toxicity of the nanomaterials [57,66].
2.4. ROS Scavenging Activities of PdNPs
Even though it is known that PdNPs possess remarkable catalytic activity [1–4,14–17], a detailed
analysis of such properties has not been performed yet [14,18,20]. Furthermore, to harness the full
potential of their antioxidant activity, an accurate control of the physico-chemical properties of the
nanomaterial is necessary, in order to engineer enzyme-mimetics for the scavenging of ROS in the
body [2,67,68].
A major role to control ROS homeostasis in biological systems is played by three antioxidant
enzymes, i.e., peroxidase (HRP), catalase (CAT), and superoxide dismutase (SOD). Here, we first
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evaluated the ability of PdNPs to mimic the antioxidant defense system in a cell-free environment
and the effect of the particle size on their performance as antioxidants. HRP is the biological enzyme
responsible for the decomposition of hydrogen peroxide (H2O2) into water, through the oxidation of
antioxidant molecules, such as glutathione. We evaluated the ability of PdNPs to act as HRP mimics
by monitoring the oxidation rate of 3,5,3′,5′-tetramethylbenzidine (TMB) in presence of H2O2. We
found that both Pd4 and Pd8 are able to efficiently catalyze the oxidation of TMB, even at very low
concentrations (Figure 7A). Interestingly, a size-dependent catalytic activity was observed, in qualitative
agreement with a previous study on PtNPs [39]. Pd4 were found to be significantly more efficient than
Pd8 in catalyzing the TMB oxidation, due to their higher surface-to-volume ratio. Remarkably, both
NPs oxidized TMB with comparable or higher performance than the natural HRP enzyme. This is likely
due to the ability of Pd nanozymes to operate in a wider range of conditions, such as non-physiological
temperature, high H2O2 concentrations, and acidic pH (required for the TMB assay), which partly
inhibit the activity of the biological enzyme [39]. Their lower sensitivity to the external conditions
(broader range of pH and temperature) suggests the superior versatility of Pd nanozymes over the
natural HRP, as artificial peroxidases in biological applications.
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The CAT enzyme catalyzes the reduction of H2O2 into water and molecular oxygen. We evaluated
CAT mimetic activity of PdNPs by measuring residual H2O2 after different incubation times (Figure 7B).
We observed a time-dependent reduction of H2O2 in presence of PdNPs or natural CAT enzyme. Pd4
nanozymes catalyze the reaction at a higher rate than Pd8, in line with their HRP activity. Both Pd4 and
Pd8 showed higher performance than the natural CAT enzyme. Finally, we investigated the SOD-like
antioxidant activity of PdNPs. We assayed the ability of Pd4 and Pd8 at different concentrations to
catalyze the dismutation of O2− into molecular oxygen and H2O2 (Figure 7C). Results showed a dose-
and size-dependent SOD-mimicking activity of NPs. Both Pd4 and Pd8 proved to be more efficient
than the SOD enzyme. In particular, Pd4 reached the same enzymatic activity of 100 U mL−1 (12 µM)
SOD [69] at considerably lower concentration (0.018 µM).
As further demonstration of the superior antioxidant properties of PdNPs, their ability to block
the production of the radical cation 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) radical cation
(ABTS+) was compared to that of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox).
Our results show that the scavenging ability of PdNPs is higher than that of the antioxidant compound,
with longer lasting performance (Supporting Figure S4).
The catalytic performance of Pd4 and Pd8 seems to be comparable to those of PtNPs with similar
size, shape, and coating [39], which are well recognized in nanomedicine for their high catalytic activity.
This is an interesting point, as it extends the list of nanomaterials that can be potentially exploited for
catalysis within cells, or for developing innovative in vitro diagnostic tools. These results also provide
evidence that our biocompatible PdNPs possess very efficient and broad antioxidant activities and,
hence, they represent a good platform to engineer highly efficient artificial antioxidant enzymes as
new therapeutic tools for the treatment of pathologies related to redox imbalance.
2.5. ROS Scavenging Effects of PdNPs in a Cellular Model of Oxidative Stress-Related Disease
Oxidative stress is associated with aging and several pathologies, including cardiovascular
diseases, cancer, and neurodegenerative disorders [70]. Moreover, the correlation between oxidative
stress and vascular dysfunctions in cerebral pathologies has been clearly demonstrated [71–73] as in the
case of the major cerebrovascular diseases of genetic origin, CCM. There is evidence that loss-of-function
mutations in one of three ccm genes, namely ccm1 (krit1), impairs cell ability to regulate mitochondrial
homeostasis, leading to ROS accumulation and consequent endothelial cell dysfunctions [74]. The high
levels of ROS in krit1 knock-out (KRIT1-KO) cells, derived from a murine model of the human CCM
pathology, makes them an optimal cellular tool [75] to test the properties of PdNPs as antioxidant
nanozymes. Therefore, we treated KRIT1-KO mouse embryonic fibroblasts (MEFs) for 48 h with
PdNPs (25 µg/mL) and we tested the ROS scavenging activity of the nanozyme by DCFH-DA assay.
A statistically significant ROS decrease in KRIT1-KO cells was observed, as compared with untreated
ones (Figure 8). Interestingly, ROS levels in treated KRIT1-KO cells reached that of the wild type
(KRIT1-WT NT), demonstrating the ability of PdNPs to act as efficient antioxidants for the recovery of
the physiological redox balance.
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Figure 8. Intracellu ar lev ls of Reactive Oxygen Species (ROS) of untreated KRIT1-KO MEF cells (NT),
KRI 1- O cells treated with 25 µg/mL PdNPs for 48 h (PdNPs), and untreated KRIT1-WT MEF cells
(NT), evaluated by DCFH-DA assay. The probe fluorescence intensity for PdNP treated KRIT1-KO cells
is reported as a percentage relative to untreated KRIT1-KO cells. Results are reported as mean ± SD.
The experiments were repeated three times and performed in triplicate.
3. Discussion
We developed a new method based on aqueous environment and reagents known to be
biocompatible, green, or easy to remove after synthesis for the production of citrate-capped PdNPs
with size tunability and low polydispersity. To the best of our knowledge, this is the first synthetic
protocol for PdNP production, performed in aqueous environment without the use of polymers,
surfactants, and other strong capping agents. Toxicological studies showed that PdNPs produced
with this method do not cause any detectable cytotoxic effect in vitro, thus suggesting their potential
for biomedical applications. Cellular internalization, fate, and analysis of NP stability/oxidation was
elucidated by TEM and SEI-XPS, demonstrating their stability within the cellular environment, a
pivotal aspect for nanozyme exploitation in nanomedicine. Our biocompatible Pd nanozymes possess
high antioxidant activity, due to their “naked” surface (fully available for the catalytic reactions) and
high surface-to-volume ratio. Such broad nanozyme properties, closely mimicking the size range
and activity of the three main antioxidant enzymes, are efficiently exerted at the intracellular level,
thanks to their large cellular uptake and stability against oxidation within the cellular environment,
as proven by SEI-XPS. This latter point not only confers them high biocompatibility, but also leaves
their catalytic efficiency within the cells virtually unaltered, thus allowing long-lasting antioxidant
activity. This is a crucial issue for practical applications of nanozymes, since they should maintain their
original physico-chemical properties in the cell environment to properly exert their function. Overall,
such intracellular stability along with the small dimensions (<10 nm) and monodispersion provide
noble metal nanozymes, such as Pt, Pd, and Au, superior performance over other artificial enzymes
such as fullerenes, cerium oxide nanoparticles, or graphene materials, where aggregation and low
cellular uptake may significantly impact their in-situ catalytic efficiency. Indeed, we observed that
our Pd nanozymes have very efficient antioxidant potential, also at the intracellular level, being able
of completely recovering the physiological ROS levels in a model of disorder induced by oxidative
stress. These findings pave the way to promising perspectives in nanomedicine for the treatment of
pathologies associated to ROS overproduction. The versatile nature of PdNPs makes them promising
candidates in the treatment of complex pathologies. Their ability to act as biorthogonal catalysts, i.e.,
to catalyze chemical reactions in vivo, combined with their antioxidant enzyme-like properties, could
be a key asset to develop multifunctional artificial enzymes for the catalysis of complex chemical
modifications. However, systematic in vivo studies on animal models will be necessary to fully disclose
their applicative potential.
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4. Materials and Methods
4.1. Chemicals
All nanoparticle syntheses were carried out in purified MilliQ water. All glass vessels were washed
with aqua regia and purified MilliQ water prior to use. Palladium(II)chloride (PdCl2), L-ascorbic acid
BioXtra product line, sodium borohydride 99.9%, sodium citrate tribasic dihydrate BioUltra product
line, citric acid anhydrous, formic acid, potassium bromide, nitric acid, and acetic acid were purchased
from Sigma-Aldrich/ Merck KGaA, Darmstadt, Germany.
4.2. Synthetic Protocol of Palladium Nanoparticles (PdNPs)
For the synthesis of Pd seeds, a 0.05 M solution of PdCl2 was prepared in 0.1M HNO3. The acidic
environment is necessary as Pd ions at neutral and basic pH tend to form polynuclear hydroxo
complexes (PHC) and precipitate in solution, which in turn strongly affects the growth mechanism [34].
Pd seeds were synthesized as follow: 160 µL of Pd solution were added to 360 mL of MilliQ water
at 0 ◦C, followed by a rapid addition of 17.6 mL solution containing 0.03 M sodium citrate and 2 mM
citric acid and 1.1 mL of NaBH4 (0.02 M), immediately after dissolution in water. The vessel was sealed
and quickly transferred to an oil bath at 100 ◦C to synthesize smaller seeds, due to a fast reduction of
the Pd ions. The reaction was kept for 10 min under magnetic stirring. After the end of the synthesis,
the vessel was removed and left to cool under stirring for an hour.
For the synthesis of 4 nm citrate-capped PdNPs (Pd4), a 0.05 M solution of PdCl2 was prepared
in 0.1 M HNO3. 320 µL of this solution were added to 180 mL of MilliQ water at room temperature,
followed by a rapid addition of 8.8 mL solution containing 0.03 M sodium citrate and 2 mM citric acid
and 2.2 mL of NaBH4 (0.02 M), immediately after dissolution in water. The vessel was sealed and
moved to an oil bath at 100 ◦C. The reaction was kept at these conditions for 10 min under magnetic
stirring. After the end of the synthesis the vessel was left to cool under stirring for another hour. After
cooling, the NPs were purified using 10 K Amicon® Ultra Centrifugal Filters, and stored in 2 mM
sodium citrate solution at 4 ◦C.
For the synthesis of 8 nm citrate-capped PdNPs (Pd8), a 0.05 M Pd ions solution was prepared by
dissolving PdCl2 in 0.1 M CH3COOH. A microwave reactor (Flexiwave Microwave Reactor, Milestone)
or a sealed glass container (ACE glass pressure reactor with Teflon cap) were used for the syntheses.
Briefly, 4 mL of Pd seeds (synthesized as mentioned above), 79.5 µL of Pd (II) solution (0.05 M), and
500 µL of a solution containing 0.34 M sodium citrate, 0.2 M formic acid, and 0.5 mM L-ascorbic acid
were added to 30 mL of MilliQ water. The vessel was then sealed, placed within the microwave chamber
(or in an oil bath in the case of sealed glass container) and brought to 105 ◦C in 5 min. The reaction was
held stationary for 10 min and then gradually cooled to room temperature. After cooling, the NPs were
washed with 2 mM sodium citrate solution using 10K Amicon® Ultra Centrifugal Filters, and stored at
4 ◦C for future experiments. The multi-vessel setup enables easy scale-up of the synthetic process.
The NP solution was also tested to be endotoxin-free following the instructions of the commercial
test Limulus Amebocyte Lysate (LAL) QCL-1000 TM (Lonza Ltd, Basel, Switzerland).
4.3. Determination of PdNP Concentration
PdNP concentration was determined via Inductively Coupled Plasma Atomic Emission
spectroscopy (ICP-AES, Agilent 720/730 spectrometer). Briefly, 10–100 µL of the PdNP solution
were dissolved in a strong oxidizing agent (aqua regia) overnight and diluted with MilliQ water to a
final volume of 10 mL. Measurements were performed at three different wavelengths (λ = 177.648,
203.646, and 214.424 nm). Each measurement was repeated in triplicate.
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4.4. Transmission Electron Microscopy (TEM) Imaging of PdNPs
PdNP size and shape were determined by using a JEOL JEM 1011 microscope, after depositing a
methanol dispersion of PdNPs on a carbon coated grid and lefting to dry under vacuum. The size of
PdNPs was obtained measuring the diameter of 300 NPs by ImageJ software.
4.5. TEM Imaging of Cellular Internalization of PdNPs
HeLa cells (400,000 cell/well in a 6-well tissue culture plate) after 24 h incubation with PdNPs
(50 µg/mL) were fixed in 0.1 M sodium cacodylate buffer at pH 7.4 containing 1.5% glutaraldehyde for
1 h. After this procedure, the cells were post fixed in the buffer described above containing 1% osmium
tetroxide and stained with an aqueous solution containing 1% uranyl acetate. After dehydratation in
graded series of ethanol, cells were embedded in epoxy resin (Epon 812, TAAB) and sectioned with
an ultramicrotome (UC6, Leica) equipped with a diamond knife (Diatome). Projection images were
obtained by a transmission electron microscope (JEOL JEM 1011, 100 kV acceleration voltage, 2 Mp
charge-coupled device (CCD) camera (Gatan Orius SC100, Gatan/AMETEK Inc, Berwyn, PA, USA)).
4.6. X-ray Photoelectron Spectroscopy (XPS) Analysis
XPS measurements were performed according to the method previously described [30].
4.7. Cell Cultures
MCF-7 (Human Mammary Gland Adenocarcinoma cells, ATCC HTB-22), HeLa (Human Cervix
Epithelioid Carcinoma cells, ECACC), Caco-2 (Human Colon Epithelial cells, ATCC HTB-37) and
MEF (Mouse Embryonic Fibroblasts, isolated from the knock-out mouse model of the human CCM
pathology) cells [74] were expanded at 37 ◦C in a humidified atmoshere containing 5% CO2 in high
glucose Dulbecco’s Modified Eagle’s Medium, DMEM (Sigma-Aldrich), containing 10% (v/v) Fetal
Bovine serum (FBS, Sigma-Aldrich), 100 mg/mL streptomycin and 100 U/mL penicillin (Sigma-Aldrich).
4.8. WST-8 Assay
The toxicological effect of increasing concentrations of PdNPs (25, 50, and 100 µg/mL) was assessed
on MCF-7, HeLa, and Caco-2 cells by WST-8 (Water Soluble Tetrazolium) assay (Sigma-Aldrich). MCF-7
(5000 cells/well), HeLa (5000 cells/well), and Caco-2 (50,000 cells/well) cells were incubated in a 96-well
tissue culture plate (Constar, Corning Inc., NY, USA) containing 100 µL of DMEM/well for 24 h at
37 ◦C in a humidified atmosphere containing 5% CO2. DMEM was then replaced with fresh medium
containing PdNPs for 24, 48, and 72 h. After washing cells three times with phosphate-buffered saline
(PBS) with Ca2+ and Mg2+, cells were incubated with DMEM containing 10% WST-8 for 1 h. Cell
viability was recorded by using an Infinite 200 Pro plate reader. Data were normalized with respect to
untreated cells (Ctrl). Results are reported as mean ± SD.
4.9. LDH Assay
Membrane damage in HeLa, MCF-7, and Caco-2 cells exposed to increasing doses of PdNPs (25,
50, and 100 µg/mL), was obtained by quantifying the release of lactate dehydrogenase (LDH), a product
of lipid peroxidation. HeLa (5000 cells/well), MCF-7 (5000 cells/well), and Caco-2 (50000 cells/well)
cells were seeded in a tissue culture-treated 96-well plate (Constar) containing 100 µL of complete
DMEM and incubated at 37 ◦C in a humidified atmosphere containing 5% CO2 for 24 h. DMEM was
then replaced with fresh medium containing PdNPs and cells were incubated for 24, 48, and 72 h.
Afterwards, the LDH assay was performed by using the CytoTox-ONE homogeneous Membrane
Integrity Assay reagent (Promega Corporation, Madison, WI, USA). Results were recorded by using an
Infinite 200 Pro plate reader. Data were normalized with respect to cells treated with lysis buffer in the
same conditions (positive control, P, expressed as 100%). Results are reported as mean ± SD.
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4.10. DCFH-DA Assay
To evaluate the effect of PdNPs on the ROS homeostasis, HeLa (20,000 cells/well), and Caco-2
(100,000 cells/well) cells were seeded in a tissue culture-treated 96-well plate (Constar) containing
100 µL of complete DMEM and incubated at 37 ◦C in a humidified atmosphere containing 5% CO2
for 24 h. DMEM was then replaced with complete medium containing 25, 50, and 100 µg/mL PdNPs
and cells were incubated for 24 h. After washing cells three times with PBS with Ca2+ and Mg2+, they
were incubated at 37 ◦C with 5 µM 2′,7′-Dichlorofluorescein diacetate (DCFH-DA, Sigma-Aldrich)
in the same buffer for 30 min. The probe fluorescence intensity was measured by an Infinite 200 Pro
plate reader, using a 480/520 nm filter set. Data were normalized with respect to cells treated with 1 M
hydrogen peroxide (H2O2) for 10 min in the same conditions (P). Results are reported as mean ± SD.
To investigate the intracellular ROS scavenging effects of PdNPs, MEF cells (15,000 cells/well)
were seeded in a tissue culture-treated 96-well plate (Constar) containing 100 µL of complete DMEM
and incubated at 37 ◦C in a humidified atmosphere containing 5% CO2 for 24 h. DMEM was then
replaced with fresh medium containing PdNPs at concentration of 25 µg/mL and cells were incubated
for 48 h. After washing cells three times with PBS with Ca2+ and Mg2+, they were incubated with 5 µM
DCFH-DA (Sigma-Aldrich) in the same buffer for 30 min at 37 ◦C. The probe fluorescence intensity was
measured by an Infinite 200 Pro plate reader, using a 480/520 nm filter set. Results were normalized
with respect to untreated cells (KRIT1-KO NT). Results are reported as mean ± SD.
4.11. Intracellular Uptake of PdNPs
PdNP cellular uptake was measured using ICP-AES (Agilent 720/730 spectrometer) analysis.
HeLa (300,000 cells/well) and Caco-2 (1,800,000 cells/well) cells were seeded in a tissue culture-treated
6-well plate (EuroClone SPA, Milan, Italy) containing complete DMEM and incubated at 37 ◦C in a
humidified atmosphere containing 5% CO2 for 24 h. DMEM was then replaced with fresh medium
containing 50 µg/mL of PdNPs and cells were incubated for 24 h. After washing cells three times with
PBS without Ca2+ and Mg2+, they were harvested using trypsin-EDTA solution. Cell number was
measured by a TC10 automatic cell counter (Bio-Rad). After a freeze/thaw lysis process, cell digestion
was conducted overnight in CEM Discover SP Microwave synthesizer using fresh aqua regia. The
solution was diluted 10 times with MilliQ water, and intracellular amount of Pd was then analyzed by
ICP-AES. Each experiment was performed in triplicate.
4.12. Antioxidant Activity of PdNPs
Peroxidase (HRP)-like activity of PdNPs was studied by monitoring the oxidation of
3,3′,5,5′-tetramethylbenzidine (TMB, BD Biosciences) at 652 nm for 10 min with a 2 s interval, by the
NanoDrop OneC spectrophotometer (Thermo Fisher Scientific Inc., Waltham, MA, USA) equipped with
a 1 cm path length cell. The reaction was performed in pH 4.7 acetate buffer, in the presence of 200 mM
H2O2 and 0.5 mM TMB, at room temperature. PdNPs were added as catalyzers at concentration of
0.05 µg/mL. Water was used instead of NPs in the Ctrl sample.
Catalase (CAT)-mimetic activity of PdNPs was evaluated by quantifying the residual H2O2 (%)
after incubation with the nanomaterial, by PeroxiDetect Kit (Sigma-Aldrich). A 40 µM solution of
H2O2 was incubated with a solution of PdNPs containing 0.5 µg/mL of Pd, at room temperature for
0, 30, 90, 180, 300, and 420 min. After the incubation time, the residual H2O2 was recorded by plate
reader. Results were compared with 40 µM H2O2 measurements over time in absence of catalyzers.
Superoxide ions scavenging ability of PdNPs was evaluated by SOD Assay Kit-WST
(Sigma-Aldrich). Superoxide dismutase (SOD) activity was recorded by Infinite 200 Pro plate reader
after 20 min of incubation at 37 ◦C, in presence of 0.05, 0.5, and 5 µg/mL PdNPs.
Antioxidant properties of PdNPs of 8 nm were compared to those of 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid (Trolox) by RANDOX assay kit (Randox Laboratories Ltd.,
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Crumlin, UK), following manufacturer’s instructions. PdNPs and Trolox were used at concentration of
77 nM and 2.22 mM, respectively. Water was used as control.
4.13. Statistical Analysis
Values are expressed as mean ± SD of three experiments. Statistical analyses were obtained by
GraphPad Prism 7 statistical analysis software (GraphPad Prism version 7.04 for Windows, GraphPad
Software, San Diego, CA, USA) applying the analysis of variance (ANOVA), using Bonferroni
post-test for multiple comparisons. Results were considered statistically significant for p-values < 0.05
(* = p < 0.05, ** = p < 0.01, and *** = p < 0.001).
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-4991/10/1/99/s1,
Figure S1: (a) TEM analysis of HeLa cells incubated with Pd8 (a–b) and Pd4 (c–e). (a) is a low magnification
projection image of late endosome/phagosome compartments containing Pd8. (b) is a higher magnification of the
boxed region in (a). (c–e) are higher magnifications of endosome/phagosome compartments containing Pd4. Scale
bars in b-e are 100 nm, Figure S2: XPS survey spectrum of HeLa cells after exposure to PdNPs for 48 hours (a)
before and (d) after 300 s of argon sputtering time. The enlarged regions between 225 and 55 eV are presented in
(b) and (e). High-resolution spectra of Pd 3d region before and after argon sputtering are presented in (c) and
(f) respectively, Figure S3: Relative percentage signal intensities for different Argon sputtering time of Pd (0),
Pdox1, Pdox2, Pdoxpr recorded on HeLa cells after exposure to Pd NPs for 48 hours, Figure S4: PdNP antioxidant
properties. Time-dependent absorbance signals at 600 nm of 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid)
radical cation (ABTS+)after incubation at 37 ◦C with 77 nM of Pd8 (grey), 2.22 mM of Trolox (purple), and water
(black) in the presence of Metmyoglobin and H2O2, Table S1: Cellular uptake of Pd4 quantified by ICP-AES in
HeLa and Caco-2 cells after treatment with 50 µg/mL of Pd4 for 24 h.
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the published version of the manuscript.
Funding: This research received no external funding.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Miller, M.A.; Askevold, B.; Mikula, H.; Kohler, R.H.; Pirovich, D.; Weissleder, R. Nano-palladium is a cellular
catalyst for in vivo chemistry. Nat. Commun. 2017, 8, 15906. [CrossRef] [PubMed]
2. Wang, X.; Guo, W.; Hu, Y.; Wu, J.; Wei, H. Metal-Based Nanomaterials for Nanozymes; Springer: Berlin,
Germany, 2016.
3. Fang, G.; Li, W.; Shen, X.; Perez-Aguilar, J.M.; Chong, Y.; Gao, X.; Chai, Z.; Chen, C.; Ge, C.; Zhou, R.
Differential Pd-nanocrystal facets demonstrate distinct antibacterial activity against Gram-positive and
Gram-negative bacteria. Nat. Commun. 2018, 9, 129. [CrossRef] [PubMed]
4. Wu, J.; Wang, X.; Wang, Q.; Lou, Z.; Li, S.; Zhu, Y.; Qin, L.; Wei, H. Nanomaterials with enzyme-like
characteristics (nanozymes): Next-generation artificial enzymes (II). Chem. Soc. Rev. 2019, 48, 1004–1076.
[CrossRef] [PubMed]
5. Chen, A.; Ostrom, C. Palladium-based nanomaterials: synthesis and electrochemical applications. Chem. Rev.
2015, 115, 11999–12044. [CrossRef]
6. Xia, Y.; Zhao, M.; Wang, X.; Huo, D. Toward affordable and sustainable use of precious metals in catalysis
and nanomedicine. MRS Bull. 2018, 43, 860–869. [CrossRef]
7. Rodrigues, T.S.; Zhao, M.; Yang, T.-H.; Gilroy, K.D.; da Silva, A.G.M.; Camargo, P.H.C.; Xia, Y. Synthesis of
colloidal metal nanocrystals: A comprehensive review on the reductants. Chem. Eur. J. 2018, 24, 16944–16963.
[CrossRef]
8. Dumas, A.; Couvreur, P. Palladium: A future key player in the nanomedical field? Chem. Sci. 2015, 6,
2153–2157. [CrossRef]
Nanomaterials 2020, 10, 99 16 of 19
9. Weiss, J.T.; Dawson, J.C.; Macleod, K.G.; Rybski, W.; Fraser, C.; Torres-Sánchez, C.; Patton, E.E.;
Bradley, M.; Carragher, N.O.; Unciti-Broceta, A. Extracellular palladium-catalysed dealkylation of
5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach. Nat. Commun. 2014, 5, 3277.
[CrossRef]
10. Weiss, J.T.; Dawson, J.C.; Fraser, C.; Rybski, W.; Torres-Sánchez, C.; Bradley, M.; Patton, E.E.; Carragher, N.O.;
Unciti-Broceta, A. Development and bioorthogonal activation of palladium-labile prodrugs of gemcitabine.
J. Med. Chem. 2014, 57, 5395–5404. [CrossRef]
11. Clavadetscher, J.; Indrigo, E.; Chankeshwara, S.V.; Lilienkampf, A.; Bradley, M. In-cell dual drug synthesis
by cancer-targeting palladium catalysts. Angew. Chem. Int. Ed. 2017, 56, 6864–6868. [CrossRef]
12. Indrigo, E.; Clavadetscher, J.; Chankeshwara, S.V.; Lilienkampf, A.; Bradley, M. Palladium-mediated in situ
synthesis of an anticancer agent. Chem. Commun. 2016, 52, 14212–14214. [CrossRef] [PubMed]
13. Weiss, J.T.; Fraser, C.; Rubio-Ruiz, B.; Myers, S.H.; Crispin, R.; Dawson, J.C.; Brunton, V.G.;
Patton, E.E.; Carragher, N.O.; Unciti-Broceta, A. N-alkynyl derivatives of 5-fluorouracil: Susceptibility to
palladium-mediated dealkylation and toxigenicity in cancer cell culture. Front. Chem. 2014, 2, 56. [CrossRef]
[PubMed]
14. Ge, C.; Fang, G.; Shen, X.; Chong, Y.; Wamer, W.G.; Gao, X.; Chai, Z.; Chen, C.; Yin, J.-J. Facet Energy versus
Enzyme-like Activities: The unexpected protection of palladium nanocrystals against oxidative damage.
ACS Nano 2016, 10, 10436–10445. [CrossRef] [PubMed]
15. Shen, X.; Liu, W.; Gao, X.; Lu, Z.; Wu, X.; Gao, X. Mechanisms of oxidase and superoxide dismutation-like
activities of gold, silver, platinum, and palladium, and their alloys: a general way to the activation of
molecular oxygen. J. Am. Chem. Soc. 2015, 137, 15882–15891. [CrossRef]
16. Li, J.; Liu, W.; Wu, X.; Gao, X. Mechanism of pH-switchable peroxidase and catalase-like activities of gold,
silver, platinum and palladium. Biomaterials 2015, 48, 37–44. [CrossRef]
17. Yang, Z.; Zhang, Z.; Jiang, Y.; Chi, M.; Nie, G.; Lu, X.; Wang, C. Palladium nanoparticles modified electrospun
CoFe2O4 nanotubes with enhanced peroxidase-like activity for colorimetric detection of hydrogen peroxide.
RSC Adv. 2016, 6, 33636–33642. [CrossRef]
18. Shibuya, S.; Ozawa, Y.; Watanabe, K.; Izuo, N.; Toda, T.; Yokote, K.; Shimizu, T. Palladium and platinum
nanoparticles attenuate aging-like skin atrophy via antioxidant activity in mice. PLoS ONE 2014, 9, e109288.
[CrossRef]
19. Wilkinson, K.E.; Palmberg, L.; Witasp, E.; Kupczyk, M.; Feliu, N.; Gerde, P.; Seisenbaeva, G.A.; Fadeel, B.;
Dahlén, S.-E.; Kessler, V.G. Solution-engineered palladium nanoparticles: model for health effect studies of
automotive particulate pollution. ACS Nano 2011, 5, 5312–5324. [CrossRef]
20. Dahal, E.; Curtiss, J.; Subedi, D.; Chen, G.; Houston, J.P.; Smirnov, S. Evaluation of the catalytic activity and
cytotoxicity of palladium nanocubes: The role of oxygen. ACS Appl. Mater. Interfaces 2015, 7, 9364–9371.
[CrossRef]
21. Ghosh, S.; Nitnavare, R.; Dewle, A.; Tomar, G.B.; Chippalkatti, R.; More, P.; Kitture, R.; Kale, S.; Bellare, J.;
Chopade, B.A. Novel platinum-palladium bimetallic nanoparticles synthesized by Dioscorea bulbifera:
Anticancer and antioxidant activities. Int. J. Nanomed. 2015, 10, 7477–7490. [CrossRef]
22. Rokade, S.S.; Joshi, K.A.; Mahajan, K.; Tomar, G.; Dubal, D.; Parihar, V.S.; Kitture, R.; Bellare, J.; Ghosh, S.
Novel anticancer platinum and palladium nanoparticles from barleria prionitis. Glob. J. Nano 2017, 2,
555–600.
23. Pan, Y.-T.; Smith, C.E.; Kwok, K.S.; Chen, J.; Kong, H.; Yang, H. Functionalized ultrathin palladium nanosheets
as patches for HepG2 cancer cells. Chem. Commun. 2015, 51, 14171–14174. [CrossRef] [PubMed]
24. Alarifi, S.; Ali, D.; Alkahtani, S.; Almeer, R.S. ROS-mediated apoptosis and genotoxicity induced by palladium
nanoparticles in human skin malignant melanoma cells. Oxid. Med. Cell. Longev. 2017, 2017, 10. [CrossRef]
[PubMed]
25. Petrarca, C.; Clemente, E.; Di Giampaolo, L.; Mariani-Costantini, R.; Leopold, K.; Schindl, R.; Lotti, L.V.;
Mangifesta, R.; Sabbioni, E.; Niu, Q.; et al. Palladium nanoparticles induce disturbances in cell cycle entry
and progression of peripheral blood mononuclear cells: paramount role of ions. J. Immunol. Res. 2014,
2014, 8. [CrossRef]
26. Iavicoli, I.; Farina, M.; Fontana, L.; Lucchetti, D.; Leso, V.; Fanali, C.; Cufino, V.; Boninsegna, A.; Leopold, K.;
Schindl, R.; et al. In vitro evaluation of the potential toxic effects of palladium nanoparticles on fibroblasts
and lung epithelial cells. Toxicol. In Vitro 2017, 42, 191–199. [CrossRef]
Nanomaterials 2020, 10, 99 17 of 19
27. Neubauer, N.; Palomaeki, J.; Karisola, P.; Alenius, H.; Kasper, G. Size-dependent ROS production by
palladium and nickel nanoparticles in cellular and acellular environments—An indication for the catalytic
nature of their interactions. Nanotoxicology 2015, 9, 1059–1066. [CrossRef]
28. Crist, R.M.; Grossman, J.H.; Patri, A.K.; Stern, S.T.; Dobrovolskaia, M.A.; Adiseshaiah, P.P.; Clogston, J.D.;
McNeil, S.E. Common pitfalls in nanotechnology: lessons learned from nci’s nanotechnology characterization
laboratory. Integr. Biol. Quant. Biosci. Nano. Macro 2013, 5, 66–73. [CrossRef]
29. Leso, V.; Iavicoli, I. Palladium nanoparticles: Toxicological effects and potential implications for occupational
risk assessment. Int. J. Mol. Sci. 2018, 19, 503. [CrossRef]
30. Turco, A.; Moglianetti, M.; Corvaglia, S.; Rella, S.; Catelani, T.; Marotta, R.; Malitesta, C.; Pompa, P.P.
Sputtering-enabled intracellular X-ray photoelectron spectroscopy: A versatile method to analyze the
biological fate of metal nanoparticles. ACS Nano 2018, 12, 7731–7740. [CrossRef]
31. Pedone, D.; Moglianetti, M.; De Luca, E.; Bardi, G.; Pompa, P.P. Platinum nanoparticles in nanobiomedicine.
Chem. Soc. Rev. 2017, 46, 4951–4975. [CrossRef]
32. Caruso, F.; Hyeon, T.; Rotello, V.M. Nanomedicine. Chem. Soc. Rev. 2012, 41, 2537–2538. [CrossRef] [PubMed]
33. Oostingh, G.J.; Casals, E.; Italiani, P.; Colognato, R.; Stritzinger, R.; Ponti, J.; Pfaller, T.; Kohl, Y.; Ooms, D.;
Favilli, F.; et al. Problems and challenges in the development and validation of human cell-based assays
to determine nanoparticle-induced immunomodulatory effects. Part. Fibre Toxicol. 2011, 8, 8. [CrossRef]
[PubMed]
34. Kettemann, F.; Wuithschick, M.; Caputo, G.; Kraehnert, R.; Pinna, N.; Rademann, K.; Polte, J. Reliable
palladium nanoparticle syntheses in aqueous solution: The importance of understanding precursor chemistry
and growth mechanism. CrystEngComm 2015, 17, 1865–1870. [CrossRef]
35. Narayanan, R.; El-Sayed, M.A. Some aspects of colloidal nanoparticle stability, catalytic activity, and recycling
potential. Top. Catal. 2008, 47, 15–21. [CrossRef]
36. Jin, M.; Liu, H.; Zhang, H.; Xie, Z.; Liu, J.; Xia, Y. Synthesis of Pd nanocrystals enclosed by {100} facets and
with sizes <10 nm for application in CO oxidation. Nano Res. 2011, 4, 83–91. [CrossRef]
37. Yuan, Q.; Zhuang, J.; Wang, X. Single-phase aqueous approach toward Pd sub-10 nm nanocubes and Pd–Pt
heterostructured ultrathin nanowires. Chem. Commun. 2009, 6613–6615. [CrossRef] [PubMed]
38. Lim, B.; Kobayashi, H.; Camargo, P.H.C.; Allard, L.F.; Liu, J.; Xia, Y. New insights into the growth mechanism
and surface structure of palladium nanocrystals. Nano Res. 2010, 3, 180–188. [CrossRef]
39. Moglianetti, M.; De Luca, E.; Pedone, D.; Marotta, R.; Catelani, T.; Sartori, B.; Amenitsch, H.; Retta, S.F.;
Pompa, P.P. Platinum nanozymes recover cellular ROS homeostasis in an oxidative stress-mediated disease
model. Nanoscale 2016, 8, 3739–3752. [CrossRef]
40. Moglianetti, M.; Solla-Gullón, J.; Donati, P.; Pedone, D.; Debellis, D.; Sibillano, T.; Brescia, R.; Giannini, C.;
Montiel, V.; Feliu, J.M.; et al. Citrate-Coated, Size-tunable octahedral platinum nanocrystals: a novel route
for advanced electrocatalysts. ACS Appl. Mater. Interfaces 2018, 10, 41608–41617. [CrossRef]
41. Adil, S.F.; Assal, M.E.; Khan, M.; Al-Warthan, A.; Siddiqui, M.R.H.; Liz-Marzán, L.M. Biogenic synthesis of
metallic nanoparticles and prospects toward green chemistry. Dalton Trans. 2015, 44, 9709–9717. [CrossRef]
42. Gatto, F.; Moglianetti, M.; Pompa, P.P.; Bardi, G. Platinum nanoparticles decrease reactive oxygen species
and modulate gene expression without alteration of immune responses in THP-1 monocytes. Nanomaterials
2018, 8, 392. [CrossRef] [PubMed]
43. Yang, T.H.; Gilroy, K.D.; Xia, Y. Reduction rate as a quantitative knob for achieving deterministic synthesis of
colloidal metal nanocrystals. Chem. Sci. 2017, 8, 6730–6749. [CrossRef] [PubMed]
44. Wang, Y.; Biby, A.; Xi, Z.; Liu, B.; Rao, Q.; Xia, X. One-pot synthesis of single-crystal palladium nanoparticles
with controllable sizes for applications in catalysis and biomedicine. ACS Appl. Nano Mater. 2019, 2,
4605–4612. [CrossRef]
45. Scott, R.W.J.; Ye, H.; Henriquez, R.R.; Crooks, R.M. Synthesis, characterization, and stability of
dendrimer-encapsulated palladium nanoparticles. Chem. Mater. 2003, 15, 3873–3878. [CrossRef]
46. Kim, S.-W.; Park, J.; Jang, Y.; Chung, Y.; Hwang, S.; Hyeon, T.; Kim, Y.W. Synthesis of monodisperse palladium
nanoparticles. Nano Lett. 2003, 3, 1289–1291. [CrossRef]
47. Smulders, S.; Kaiser, J.-P.; Zuin, S.; Van Landuyt, K.L.; Golanski, L.; Vanoirbeek, J.; Wick, P.; Hoet, P.H.M.
Contamination of nanoparticles by endotoxin: Evaluation of different test methods. Part. Fibre Toxicol. 2012,
9, 41. [CrossRef]
Nanomaterials 2020, 10, 99 18 of 19
48. Kang, S.; Shin, W.; Kang, K.; Choi, M.H.; Kim, Y.J.; Kim, Y.K.; Min, D.H.; Jang, H. Revisiting of Pd Nanoparticles
in cancer treatment: all-round excellence of porous pd nanoplates in gene-thermo combinational therapy.
ACS Appl. Mater. Interfaces 2018, 10, 13819–13828. [CrossRef]
49. Zhao, Z.; Shi, S.; Huang, Y.; Tang, S.; Chen, X. Simultaneous photodynamic and photothermal therapy using
photosensitizer-functionalized Pd nanosheets by single continuous wave laser. ACS Appl. Mater. Interfaces
2014, 6, 8878–8885. [CrossRef]
50. Tang, S.; Chen, M.; Zheng, N. Multifunctional ultrasmall Pd nanosheets for enhanced near-infrared
photothermal therapy and chemotherapy of cancer. Nano Res. 2015, 8, 165–174. [CrossRef]
51. Rubio-Ruiz, B.; Pérez-López, A.M.; Bray, T.L.; Lee, M.; Serrels, A.; Prieto, M.; Arruebo, M.; Carragher, N.O.;
Sebastián, V.; Unciti-Broceta, A. High-precision photothermal ablation using biocompatible palladium
nanoparticles and laser scanning microscopy. ACS Appl. Mater. Interfaces 2018, 10, 3341–3348. [CrossRef]
52. Huang, X.; Tang, S.; Liu, B.; Ren, B.; Zheng, N. Enhancing the Photothermal Stability of Plasmonic Metal
Nanoplates by a Core-Shell Architecture. Adv. Mater. 2011, 23, 3420–3425. [CrossRef] [PubMed]
53. Hildebrand, H.; Kühnel, D.; Potthoff, A.; Mackenzie, K.; Springer, A.; Schirmer, K. Evaluating the cytotoxicity
of palladium/magnetite nano-catalysts intended for wastewater treatment. Environ. Pollut. 2010, 158, 65–73.
[CrossRef] [PubMed]
54. Bharathiraja, S.; Bui, N.Q.; Manivasagan, P.; Moorthy, M.S.; Mondal, S.; Seo, H.; Phuoc, N.T.; Vy Phan, T.T.;
Kim, H.; Lee, K.D.; et al. Multimodal tumor-homing chitosan oligosaccharide-coated biocompatible
palladium nanoparticles for photo-based imaging and therapy. Sci. Rep. 2018, 8, 500. [CrossRef] [PubMed]
55. Long, N.V.; Thi, C.; Yang, Y.; Nogami, M.; Ohtaki, M. Platinum and palladium nano-structured catalysts for
polymer electrolyte fuel cells and direct methanol fuel cells. J. Nanosci. Nanotechnol. 2013, 13, 4799–4824.
[CrossRef]
56. Long, R.; Mao, K.; Ye, X.; Yan, W.; Huang, Y.; Wang, J.; Fu, Y.; Wang, X.; Wu, X.; Xie, Y.; et al. Surface Facet of
Palladium Nanocrystals: A Key Parameter to the Activation of Molecular Oxygen for Organic Catalysis and
Cancer Treatment. J. Am. Chem. Soc. 2013, 135, 3200–3207. [CrossRef]
57. De Matteis, V.; Malvindi, M.A.; Galeone, A.; Brunetti, V.; De Luca, E.; Kote, S.; Kshirsagar, P.; Sabella, S.;
Bardi, G.; Pompa, P.P. Negligible particle-specific toxicity mechanism of silver nanoparticles: The role of Ag+
ion release in the cytosol. Nanomed. Nanotechnol. Biol. Med. 2015, 11, 731–739. [CrossRef]
58. Fotakis, G.; Timbrell, J.A. In vitro cytotoxicity assays: Comparison of LDH, neutral red, MTT and protein
assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol. Lett. 2006, 160, 171–177.
[CrossRef]
59. Duan, J.; Yu, Y.; Li, Y.; Yu, Y.; Li, Y.; Zhou, X.; Huang, P.; Sun, Z. Toxic effect of silica nanoparticles on
endothelial cells through DNA damage response via Chk1-dependent G2/M checkpoint. PLoS ONE 2013,
8, e62087. [CrossRef]
60. Gomes, A.; Fernandes, E.; Lima, J.L.F.C. Fluorescence probes used for detection of reactive oxygen species. J.
Biochem. Biophys. Methods 2005, 65, 45–80. [CrossRef]
61. Wang, H.; Joseph, J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate
reader11Mention of a trade name, proprietary product, or specific equipment does not constitute a guarantee
by the United States Department of Agriculture and does not imply its approval to the exclusion of other
products that may be suitable. Free Radic. Biol. Med. 1999, 27, 612–616. [CrossRef]
62. Guarnieri, D.; Melone, P.; Moglianetti, M.; Marotta, R.; Netti, P.A.; Pompa, P.P. Particle size affects the cytosolic
delivery of membranotropic peptide-functionalized platinum nanozymes. Nanoscale 2017, 9, 11288–11296.
[CrossRef] [PubMed]
63. Van der Zande, M.; Undas, A.K.; Kramer, E.; Monopoli, M.P.; Peters, R.J.; Garry, D.; Antunes Fernandes, E.C.;
Hendriksen, P.J.; Marvin, H.J.P.; Peijnenburg, A.A.; et al. Different responses of Caco-2 and MCF-7 cells to
silver nanoparticles are based on highly similar mechanisms of action. Nanotoxicology 2016, 10, 1431–1441.
[CrossRef] [PubMed]
64. Peuckert, M. XPS study on surface and bulk palladium oxide, its thermal stability, and a comparison with
other noble metal oxides. J. Phys. Chem. 1985, 89, 2481–2486. [CrossRef]
65. López-Vinasco, A.M.; Favier, I.; Pradel, C.; Huerta, L.; Guerrero-Ríos, I.; Teuma, E.; Gómez, M.; Martin, E.
Unexpected bond activations promoted by palladium nanoparticles. Dalton Trans. 2014, 43, 9038–9044.
[CrossRef]
Nanomaterials 2020, 10, 99 19 of 19
66. Sabella, S.; Carney, R.P.; Brunetti, V.; Malvindi, M.A.; Al-Juffali, N.; Vecchio, G.; Janes, S.M.; Bakr, O.M.;
Cingolani, R.; Stellacci, F.; et al. A general mechanism for intracellular toxicity of metal-containing
nanoparticles. Nanoscale 2014, 6, 7052–7061. [CrossRef]
67. Wei, H.; Wang, E. Nanomaterials with enzyme-like characteristics (nanozymes): Next-generation artificial
enzymes. Chem. Soc. Rev. 2013, 42, 6060–6093. [CrossRef]
68. Zhou, Y.; Liu, B.; Yang, R.; Liu, J. Filling in the Gaps between Nanozymes and Enzymes: Challenges and
Opportunities. Bioconjug. Chem. 2017, 28, 2903–2909. [CrossRef]
69. SOD Determination Kit, Datasheet n. 19160. 2018, pp. 1–4. Available online: https://www.sigmaaldrich.com/
content/dam/sigma-aldrich/docs/Sigma/Datasheet/6/19160dat.pdf (accessed on 17 March 2015).
70. Liguori, I.; Russo, G.; Curcio, F.; Bulli, G.; Aran, L.; Della-Morte, D.; Gargiulo, G.; Testa, G.; Cacciatore, F.;
Bonaduce, D.; et al. Oxidative stress, aging, and diseases. Clin. Interv. Aging 2018, 13, 757–772. [CrossRef]
71. Faraci, F.M. Protecting against vascular disease in brain. Am. J. Physiol. Heart Circ. Physiol. 2011, 300,
1566–1582. [CrossRef]
72. Fraser, P.A. The role of free radical generation in increasing cerebrovascular permeability. Free Radic. Biol. Med.
2011, 51, 967–977. [CrossRef]
73. Chrissobolis, S.; Miller, A.A.; Drummond, G.R.; Kemp-Harper, B.K.; Sobey, C.G. Oxidative stress and
endothelial dysfunction in cerebrovascular disease. Front. Biosci. 2011, 16, 1733–1745. [CrossRef] [PubMed]
74. Goitre, L.; Balzac, F.; Degani, S.; Degan, P.; Marchi, S.; Pinton, P.; Retta, S.F. KRIT1 Regulates the Homeostasis
of Intracellular Reactive Oxygen Species. PLoS ONE 2010, 5, 11786. [CrossRef] [PubMed]
75. De Luca, E.; Pedone, D.; Moglianetti, M.; Pulcini, D.; Perrelli, A.; Retta, S.F.; Pompa, P.P.
Multifunctional Platinum@BSA–Rapamycin Nanocarriers for the Combinatorial Therapy of Cerebral
Cavernous Malformation. ACS Omega 2018, 3, 15389–15398. [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
